| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.15▲ | 2.15▲ | 2.16▲ | 2.12▲ | 2.11▲ |
| MA10 | 2.15▲ | 2.17▲ | 2.16▲ | 2.04▲ | 2.27▼ |
| MA20 | 2.14▲ | 2.16▲ | 2.12▲ | 2.10▲ | 2.41▼ |
| MA50 | 2.17▲ | 2.10▲ | 2.09▲ | 2.30▼ | 1.81▲ |
| MA100 | 2.15▲ | 2.09▲ | 2.03▲ | 2.41▼ | 1.53▲ |
| MA200 | 2.11▲ | 2.04▲ | 2.19▼ | 1.95▲ | 2.91▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | -0.006▼ | 0.002▲ | 0.030▲ | -0.092▼ |
| RSI | 66.053▲ | 58.031▲ | 59.771▲ | 50.553▲ | 49.979▼ |
| STOCH | 75.000 | 27.315 | 59.398 | 85.602▲ | 22.302 |
| WILL %R | 0.000▲ | -37.500 | -25.000▲ | -12.500▲ | -62.832 |
| CCI | 254.433▲ | -32.473 | 40.730 | 113.946▲ | -90.480 |
| CDL | $FATE Doji Candlestick Pattern Detected | Set Alert |
|
Monday, October 26, 2026 05:08 AM
Fate Therapeutics reports preliminary FT819 lupus nephritis responses, a 50% mean reduction in urine protein-to-creatinine ratio and ...
|
|
Friday, October 02, 2026 12:01 AM
SAN DIEGO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent ...
|
|
Friday, September 25, 2026 01:30 AM
Fate Therapeutics (NASDAQ:FATE) receives a $15 million CIRM grant to support the Phase 2 RECLAIM-LN trial of FT819 CAR T-cell therapy.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/10/26 | 2.17 | 2.23 | 2.12 | 2.17 | 804,287 |
| 28/10/26 | 2.04 | 2.18 | 2.035 | 2.17 | 1,105,654 |
| 27/10/26 | 2.05 | 2.09 | 2.03 | 2.07 | 923,556 |
| 26/10/26 | 2.10 | 2.14 | 2.04 | 2.055 | 1,460,286 |
| 23/10/26 | 2.08 | 2.135 | 2.015 | 2.11 | 1,111,188 |
| 22/10/26 | 2.07 | 2.11 | 2.035 | 2.09 | 867,180 |
| 21/10/26 | 2.06 | 2.14 | 2.045 | 2.07 | 1,215,151 |
| 20/10/26 | 1.86 | 2.145 | 1.84 | 2.06 | 1,772,349 |
| 19/10/26 | 1.79 | 1.90 | 1.75 | 1.86 | 1,683,530 |
| 16/10/26 | 1.94 | 1.975 | 1.78 | 1.79 | 1,384,493 |
|
|
||||
|
|
||||
|
|